Perilla Leaf Extract (Shiso)

Perilla frutescens
Evidence Level
Limited
2 Clinical Trials
5 Documented Benefits
2/5 Evidence Score

Perilla (shiso) is a Lamiaceae family herb widely used as a culinary and medicinal plant in Japan, Korea, and China. Leaf extracts standardized to rosmarinic acid and luteolin have been studied for seasonal allergic rhinitis, anti-inflammatory activity, and cognitive support. The most cited human evidence comes from a Japanese placebo-controlled trial showing reduced allergic rhinoconjunctivitis symptoms with a rosmarinic-acid-enriched extract, along with reduced neutrophil and eosinophil nasal infiltration. Preclinical work supports antioxidant and neuroprotective activity in cognition models. The seed oil is also used as an omega-3 (ALA) source. Generally well-tolerated; the herb has a long culinary safety record.

Studied Dose 50-200 mg/day of rosmarinic-acid-standardized leaf extract; trial dose was 50-200 mg rosmarinic acid daily. For seed oil: 1-3 g/day as ALA source.
Active Compound Rosmarinic acid (typically standardized to 1-5% in extracts), luteolin, apigenin, and triterpene acids; perilla seed oil also contains 50-60% alpha-linolenic acid (ALA omega-3).

Benefits

Seasonal Allergy Symptom Support

Rosmarinic-acid-enriched perilla leaf extract has been studied for reducing seasonal allergic rhinoconjunctivitis symptoms including itchy nose, watery and itchy eyes. A placebo-controlled trial reported improved responder rates and reduced inflammatory cell infiltration in the nasal mucosa.

Anti-Inflammatory Activity

Rosmarinic acid and luteolin from perilla act on multiple inflammatory pathways, including suppression of arachidonic acid metabolism and reduced cytokine production. This may support general inflammatory balance, particularly in mucosal tissues.

Antioxidant Defense

Perilla leaf polyphenols scavenge free radicals and support endogenous antioxidant capacity in cell and animal models. The plant's traditional use as a 'cleansing' herb in East Asian medicine aligns with this mechanistic property.

Respiratory Mucosal Support

By reducing local mucosal inflammation and inflammatory cell infiltration, perilla extracts may support respiratory comfort during allergy season. Effects appear in days-to-weeks of consistent use rather than as an acute decongestant action.

ALA Omega-3 Source (Seed Oil)

Perilla seed oil is one of the richest plant sources of alpha-linolenic acid (ALA), the plant omega-3 precursor. This makes perilla a culinary and supplemental option for those seeking plant-based omega-3 intake to support cardiovascular and inflammatory balance.

Mechanism of action

1

Rosmarinic Acid Anti-Allergic Activity

Rosmarinic acid inhibits complement activation and reduces histamine release from mast cells, dampening the IgE-mediated allergic cascade. It also suppresses eosinophil and neutrophil infiltration of inflamed mucosa, reducing local symptom severity.

2

Luteolin Inflammatory Suppression

Luteolin, a flavone abundant in perilla leaves, inhibits NF-kB activation and reduces transcription of pro-inflammatory genes including TNF-alpha, IL-6, and COX-2. This contributes to perilla's broad anti-inflammatory pharmacology.

3

Antioxidant Polyphenol Activity

Perilla polyphenols directly scavenge reactive oxygen species and chelate transition metals that catalyze oxidative damage. They also upregulate endogenous antioxidant systems including glutathione peroxidase and superoxide dismutase.

4

Acetylcholinesterase Modulation

Perilla extracts have demonstrated mild inhibition of acetylcholinesterase in preclinical assays, supporting acetylcholine availability for memory and cognition. This mechanism underlies preliminary cognitive-support investigations in animal models.

Clinical trials

1
Perilla Rosmarinic Acid Extract for Allergic Rhinoconjunctivitis

Randomized, double-blind, placebo-controlled trial of Perilla frutescens extract enriched for rosmarinic acid (50 or 200 mg/day) for 21 days in adults with mild seasonal allergic rhinoconjunctivitis. Symptom diaries, responder rates, and nasal lavage cell counts assessed. (Takano et al, Exp Biol Med)

Adults with mild seasonal allergic rhinoconjunctivitis. 21-day intervention.

Perilla extract significantly increased responder rates for itchy nose, watery eyes, itchy eyes, and total symptoms compared to placebo. Reduced neutrophil and eosinophil infiltration in nasal lavage fluid was observed. No adverse events were reported, supporting tolerability across the dose range.

2
Perilla Frutescens Extract Cognitive Protection — Animal Model

Preclinical study of Perilla frutescens extract in mice exposed to a neurotoxin (trimethyltin chloride), examining acetylcholinesterase activity and learning/memory performance. (Choi et al, J Med Food)

Mouse neurotoxin model. Preclinical.

Perilla extract significantly reduced acetylcholinesterase activity and reversed learning/memory impairment in the trimethyltin-treated mice. Mechanism appears related to cholinergic support and antioxidant activity. Provides preclinical rationale for cognitive applications; human cognitive trial data remain limited.

Side effects and drug interactions

Common Potential side effects

Generally well-tolerated; long culinary safety history.
Rare allergic reactions in individuals sensitive to mint family (Lamiaceae) herbs.
Mild GI upset possible at higher doses.
Perilla seed oil may oxidize quickly; store cool and use fresh.
Some traditional reports of cyanogenic precursors in leaves at very high intakes; supplement extracts are safe at studied doses.

Important Drug interactions

Antiplatelet and anticoagulant drugs (warfarin, aspirin) — high-dose rosmarinic acid may modestly affect platelet activity; monitor
Antihypertensive medications — perilla extracts may modestly lower blood pressure; monitor when initiating
Sedative medications — luteolin has mild anxiolytic activity; possible additive sedation at high doses
Acetylcholinesterase inhibitor medications (donepezil) — theoretical additive cholinergic effects; discuss with prescriber

Frequently asked questions about Perilla Leaf Extract (Shiso)

What is the recommended dosage of Perilla Leaf Extract (Shiso)?

The clinically studied dose for Perilla Leaf Extract (Shiso) is 50-200 mg/day of rosmarinic-acid-standardized leaf extract; trial dose was 50-200 mg rosmarinic acid daily. For seed oil: 1-3 g/day as ALA source.. Always follow product labeling and consult a healthcare provider for personalized dosing recommendations.

What is Perilla Leaf Extract (Shiso) used for?

Perilla Leaf Extract (Shiso) is studied for seasonal allergy symptom support, anti-inflammatory activity, antioxidant defense. Rosmarinic-acid-enriched perilla leaf extract has been studied for reducing seasonal allergic rhinoconjunctivitis symptoms including itchy nose, watery and itchy eyes.

Are there side effects from taking Perilla Leaf Extract (Shiso)?

Reported potential side effects may include: Generally well-tolerated; long culinary safety history. Rare allergic reactions in individuals sensitive to mint family (Lamiaceae) herbs. Always consult a healthcare provider before starting any new supplement, especially if you have underlying conditions or take medications.

Does Perilla Leaf Extract (Shiso) interact with medications?

Known drug interactions may include: Antiplatelet and anticoagulant drugs (warfarin, aspirin) — high-dose rosmarinic acid may modestly affect platelet activity; monitor Antihypertensive medications — perilla extracts may modestly lower blood pressure; monitor when initiating Consult a pharmacist or healthcare provider if you take prescription medications.

Is Perilla Leaf Extract (Shiso) good for anti-inflammatory?

Yes, Perilla Leaf Extract (Shiso) is researched for Anti-Inflammatory support. Rosmarinic acid and luteolin from perilla act on multiple inflammatory pathways, including suppression of arachidonic acid metabolism and reduced cytokine production. This may support general inflammatory balance, particularly in mucosal tissues.

References(3 citations)

Evidence ratings on NutraSmarts are based on the totality of human clinical research, with emphasis on randomized controlled trials, meta-analyses, and systematic reviews. The references below directly support claims made throughout this page.

  1. Takano H, Osakabe N, Sanbongi C, Yanagisawa R, Inoue K, Yasuda A, Natsume M, Baba S, Ichiishi E, Yoshikawa T. Extract of Perilla frutescens enriched for rosmarinic acid, a polyphenolic phytochemical, inhibits seasonal allergic rhinoconjunctivitis in humans. Exp Biol Med (Maywood). 2004;229(3):247-54. doi: 10.1177/153537020422900305.PubMedUsed to support: Foundational RCT — Perilla frutescens extract enriched in rosmarinic acid significantly improved responder rates for itchy nose, watery eyes, itchy eyes, and total symptoms in seasonal allergic rhinoconjunctivitis; reduced neutrophil/eosinophil nasal infiltration
  2. Osakabe N, Takano H, Sanbongi C, Yasuda A, Yanagisawa R, Inoue K, Yoshikawa T. Anti-inflammatory and anti-allergic effect of rosmarinic acid (RA); inhibition of seasonal allergic rhinoconjunctivitis (SAR) and its mechanism. Biofactors. 2004;21(1-4):127-31. doi: 10.1002/biof.552210125.PubMedUsed to support: Mechanistic review of rosmarinic acid (from perilla) in allergic rhinoconjunctivitis; supports the inflammatory-pathway mechanisms (mast cell, eosinophil) underlying clinical anti-allergy effect of perilla extract
  3. Choi SJ, Oh SS, Kim CR, Kwon YK, Suh SH, Kim JK, Park GG, Son SY, Shin DH. Perilla frutescens Extract Ameliorates Acetylcholinesterase and Trimethyltin Chloride-Induced Neurotoxicity. J Med Food. 2016;19(3):281-9. doi: 10.1089/jmf.2015.3540.PubMedUsed to support: Preclinical mouse model showing perilla extract reduced acetylcholinesterase activity and reversed learning/memory impairment induced by neurotoxin; preclinical basis for cognitive-support investigations